1. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
   Robert B. Wilson et al, 2020, International Journal of Molecular Sciences CrossRef
2. Analysis of endoscopic and pathological features of 6961 cases of gastric cancer
   Junhui Lu et al, 2024, Scientific Reports CrossRef
3. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper
   Tom Alan Ranger et al, 2021, BMJ Open CrossRef
4. Tamoxifen Downregulates the Expression of Notch1 and DLL1 Genes in MKN-45 Gastric Cancer Cells
   Faranak Khanipouyani et al, 2021, Journal of Gastrointestinal Cancer CrossRef
5. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales
   Úna McMenamin et al, 2021, BMC Cancer CrossRef
6. Astilbin Inhibits the Proliferation and Induces Apoptosis of Gastric Cancer Cells (AGS) by Targeting the Key Inflammatory Markers
   Guoshan Zhang et al, 2024, Pharmacognosy Magazine CrossRef
7. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis
   Kehui Zhang et al, 2022, Frontiers in Oncology CrossRef
8. Tamoxifen inhibits fibroblast proliferation and prevents epidural fibrosis by regulating the AKT pathway in rats
   Shuguang Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
9. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug
   Ghadier Matariek et al, 2022, European Journal of Medical and Health Sciences CrossRef
10. Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records
    Chris R. Cardwell et al, 2024, British Journal of Cancer CrossRef
11. Does tamoxifen have a therapeutic role outside of breast cancer? A systematic review of the evidence
    R.E. Clifford et al, 2020, Surgical Oncology CrossRef